Your browser doesn't support javascript.
loading
Questioning universal use of O- red blood cells in intrauterine transfusions.
Johnson, Olivia G; Rose, William N.
Afiliación
  • Johnson OG; Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI (Ms Johnson).
  • Rose WN; Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital, Madison, WI (Dr Rose).
AJOG Glob Rep ; 3(2): 100202, 2023 May.
Article en En | MEDLINE | ID: mdl-37234815
ABSTRACT
In the setting of maternal alloimmunization to antigen(s) on fetal red blood cells, significant fetal anemia may develop, and an intrauterine transfusion may be required. When selecting a blood product for intrauterine transfusion, the priority should be crossmatch compatibility with the mother. Preventing fetal alloimmunization is not practical or necessary. Universal use of O- red blood cells is not appropriate for pregnant women who are alloimmunized to c or e antigens and require an intrauterine transfusion. Essentially, 100% of people who are D- are homozygous for both c and e antigens. Thus, it is logistically impossible to find red blood cells that is D-c- or D-e-, and O+ red blood cells is necessary in the context of maternal alloimmunization to c or e antigens.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: AJOG Glob Rep Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: AJOG Glob Rep Año: 2023 Tipo del documento: Article